Northern Trust’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.43M | Buy |
761,419
+388,212
| +104% | +$1.75M | ﹤0.01% | 2690 |
|
|
2025
Q1 | $1.73M | Sell |
373,207
-3,757
| -1% | -$17.4K | ﹤0.01% | 2996 |
|
|
2024
Q4 | $2.62M | Buy |
376,964
+18,391
| +5% | +$128K | ﹤0.01% | 2862 |
|
|
2024
Q3 | $1.9M | Buy |
358,573
+64,377
| +22% | +$341K | ﹤0.01% | 3036 |
|
|
2024
Q2 | $1.1M | Buy |
294,196
+3,742
| +1% | +$14K | ﹤0.01% | 3200 |
|
|
2024
Q1 | $2.05M | Buy |
290,454
+5,520
| +2% | +$38.9K | ﹤0.01% | 2948 |
|
|
2023
Q4 | $1.61M | Sell |
284,934
-159,028
| -36% | -$899K | ﹤0.01% | 3107 |
|
|
2023
Q3 | $2.13M | Buy |
443,962
+15,473
| +4% | +$74.1K | ﹤0.01% | 2905 |
|
|
2023
Q2 | $2.94M | Buy |
428,489
+177,962
| +71% | +$1.22M | ﹤0.01% | 2792 |
|
|
2023
Q1 | $1.95M | Sell |
250,527
-4,584
| -2% | -$35.7K | ﹤0.01% | 2946 |
|
|
2022
Q4 | $1.94M | Buy |
255,111
+6,961
| +3% | +$53K | ﹤0.01% | 3015 |
|
|
2022
Q3 | $2.03M | Buy |
248,150
+24,385
| +11% | +$199K | ﹤0.01% | 3003 |
|
|
2022
Q2 | $2.16M | Buy |
223,765
+4,027
| +2% | +$38.9K | ﹤0.01% | 3015 |
|
|
2022
Q1 | $3.08M | Buy |
219,738
+111,573
| +103% | +$1.56M | ﹤0.01% | 2867 |
|
|
2021
Q4 | $2.21M | Buy |
108,165
+4,168
| +4% | +$85.1K | ﹤0.01% | 3176 |
|
|
2021
Q3 | $2.32M | Buy |
+103,997
| New | +$2.32M | ﹤0.01% | 3213 |
|